Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-14, Stock:JNJ, The news for the past five days is as follows:
2019-02-07: NEWS1: J&J becomes first drugmaker to add prices to television ads.NEWS2: Johnson & Johnson will list drug prices in TV commercials.NEWS3: Johnson & Johnson will list drug prices in TV commercials.NEWS4: DBC, SHE: Big ETF Outflows.NEWS5: DBC, SHE: Big ETF Outflows.NEWS6: Health Care Sector Update for 02/07/2019: LCI, OSUR, CAH, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 02/07/2019: LCI, OSUR, CAH, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Swiss Idorsia says 'stay tuned' for deals as it manages pipeline.NEWS9: Idorsia will take three to four years to reach profitability, CEO says.
2019-02-08: NEWS1: Here&apos;s Why Arrowhead Pharmaceuticals Gained as Much as 15.8% Today.NEWS2: Johnson & Johnson Rolls Out a New Trump Appeasement Policy.NEWS3: Health Care Sector Update for 02/08/2019: APOP, SGEN, MBOT, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Health Care Sector Update for 02/08/2019: APOP, SGEN, MBOT, JNJ, PFE, ABT, MRK, AMGN.NEWS5: The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs.NEWS6: Apple teams up with Johnson & Johnson to help prevent strokes.NEWS7: See what the IHS Markit Score report has to say about Johnson & Johnson..
2019-02-11: NEWS1: SEC&apos;s Clayton says agency right not to rule on Johnson & Johnson shareholder proposal concerning mandatory arbitration.NEWS2: SEC's Clayton says agency right not to rule on Johnson & Johnson shareholder proposal concerning mandatory arbitration.NEWS3: FDA Panel Reviews Johnson & Johnson's Treatment-Resistant Depression Candidate: What To Expect.NEWS4: What Are Analysts Saying About Johnson & Johnson’s (NYSE:JNJ) Growth?.
2019-02-12: NEWS1: J&J's nasal spray for depression wins FDA panel backing.NEWS2: U.S. FDA panel recommends approval of Johnson & Johnson's depression drug.NEWS3: Dow Analyst Moves: JNJ.NEWS4: Dow Analyst Moves: JNJ.NEWS5: [$$] SEC Allows Rejection of Mandatory Shareholder Arbitration.NEWS6: ARWR’s 2019 Goals Include Data From Several Studies, Initiation of Ph2 ARO-AAT.NEWS7: Health Care Sector Update for 02/12/2019: KMDA, GILD, MDGS, JNJ, PFE, MRK, ABT, AMGN.NEWS8: Health Care Sector Update for 02/12/2019: KMDA, GILD, MDGS, JNJ, PFE, MRK, ABT, AMGN.NEWS9: The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares.NEWS10: [$$] SEC Rejects Proposal for Mandatory Shareholder Arbitration.
2019-02-13: NEWS1: Johnson & Johnson supplier seeks bankruptcy over talc lawsuits.NEWS2: Imerys Talc Units File Bankruptcy as Cancer-Suit Risk Soars.NEWS3: [$$] Johnson & Johnson Talc Supplier Files for Bankruptcy.NEWS4: Johnson & Johnson supplier seeks bankruptcy over talc lawsuits.NEWS5: Here Is What&apos;s Surprising About J&J&apos;s Robotic Surgery Buyout.NEWS6: Dow Ends Off Highs but Optimism Remains Over a U.S.-China Trade Deal.NEWS7: Stocks rise as Trump signals China trade flexibility.NEWS8: The Funded: 9 Bay Area startups raising nearly $900M at midweek.NEWS9: Why Geron Stock Briefly Spiked Today.NEWS10: Why Geron Stock Briefly Spiked Today.NEWS11: Dow Jones Today: J&J Buys Robotics Firm; Cisco Systems Falls Ahead Of Earnings.NEWS12: Imerys Talc America files for bankruptcy under weight of talc litigation.NEWS13: Traders boost the wrong stock for a second time after J&J takeover.NEWS14: Traders boost the wrong stock for a second time after J&J takeover.NEWS15: Dow Comes Off Highs but Optimism Remains Over a U.S.-China Trade Deal.NEWS16: Imerys Talc America to file for Chapter 11 bankruptcy - statement.NEWS17: Johnson & Johnson to Buy Robotic Surgery Company Auris Health for $3.4 Billion.NEWS18: Why Geron Stock Briefly Spiked Today.NEWS19: J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod.NEWS20: J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod.NEWS21: Noteworthy ETF Outflows: XLV, JNJ, GILD, CVS.NEWS22: Noteworthy ETF Outflows: XLV, JNJ, GILD, CVS.NEWS23: Johnson & Johnson to buy surgical robotics firm Auris for $3.4 billion.NEWS24: Johnson & Johnson delves into robotics, buys Auris Health for $3.4 billion.NEWS25: Johnson & Johnson to pay $3.4B to buy Auris Health.NEWS26: Case of Mistaken Identity Sends Auris Medical Shares Soaring 30%.NEWS27: J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod.NEWS28: Johnson & Johnson Makes $3.4 Billion Buy Into Robotic Surgery Field.NEWS29: Stocks Extend Rally as Trade Optimism Buoys Wall Street.NEWS30: Johnson & Johnson Wins FDA Panel Backing For Nasal Spray Depression Drug; PDUFA Date Awaits.NEWS31: Health Care Sector Update for 02/13/2019: BABY, TEVA, EXEL, JNJ, PFE, ABT, MRK, AMGN.NEWS32: Health Care Sector Update for 02/13/2019: BABY, TEVA, EXEL, JNJ, PFE, ABT, MRK, AMGN.NEWS33: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 14, 2019.NEWS34: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 14, 2019.NEWS35: Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 14, 2019.NEWS36: Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 14, 2019.NEWS37: Johnson & Johnson will acquire surgical robotics company Auris Health.NEWS38: Johnson & Johnson to buy Auris Health for $3.4 billion.NEWS39: Johnson & Johnson to buy Auris Health for $3.4 billion.NEWS40: Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc..NEWS41: The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering.NEWS42: PRESS DIGEST-New York Times business news - Feb 13.NEWS43: [$$] Johnson & Johnson to buy robotics group Auris Health for $3.4bn.

Answer: Decrease